Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Urea + Vitamin E is a topical dermatological combination therapy primarily indicated for the treatment of hyperkeratotic and severely dry skin conditions, including psoriasis, eczema, ichthyosis, and keratosis pilaris. Urea acts as a potent humectant and keratolytic agent; it increases the water-binding capacity of the stratum corneum and, at therapeutic concentrations, promotes the shedding of dead skin cells by disrupting hydrogen bonds in keratin. Vitamin E (typically included as alpha-tocopheryl acetate) serves as a lipid-soluble antioxidant that protects skin cell membranes from oxidative damage caused by free radicals and environmental stressors. Together, these ingredients work synergistically to restore the skin's moisture barrier, soften rough or thickened skin, and improve overall skin texture and elasticity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on urea + vitamin e.